advertisement

---

Goldberg I 6

Showing records 1 to 6 | Display all abstracts from Goldberg I

59302 Cataract and quality of life in patients with glaucoma
Skalicky SE; Martin KR; Fenwick E; Crowston JG; Goldberg I; McCluskey P
Clinical and Experimental Ophthalmology 2015; 43: 335-341

---

59117 Severe intraocular pressure response to periocular or intravitreal steroid treatment in Australia and New Zealand: data from the Australian and New Zealand Ophthalmic Surveillance Unit
Fitzgerald JT; Saunders L; Ridge B; White AJ; Goldberg I; Clark B; Mills RA; Craig JE
Clinical and Experimental Ophthalmology 2015; 43: 234-238

---

59224 Brinzolamide plus brimonidine for the treatment of glaucoma: an update
Chew SK; Skalicky SE; Goldberg I
Expert Opinion in Pharmacotherapy 2014; 15: 2461-2471

---

58836 Twice-Daily Brinzolamide/Brimonidine Fixed Combination versus Brinzolamide or Brimonidine in Open-Angle Glaucoma or Ocular Hypertension
Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
Ophthalmology 2014; 121: 2348-2355

---

59068 Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease
Goldberg I; Graham SL; Crowston JG; d'Mellow G;
Clinical and Experimental Ophthalmology 2015; 43: 214-220

---

59297 Intraocular pressure-lowering medications and long-term outcomes of selective laser trabeculoplasty
Woo DM; Healey PR; Graham SL; Goldberg I
Clinical and Experimental Ophthalmology 2015; 43: 320-327

---